Loading clinical trials...
Loading clinical trials...
This phase II trial is studying how well tipifarnib works in treating young patients with recurrent or progressive high-grade glioma, medulloblastoma, primitive neuroectodermal tumor, or brain stem gl...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
National Cancer Institute (NCI)
NCT00381797 · Childhood Cerebral Anaplastic Astrocytoma, Childhood Oligodendroglioma, and more
NCT02194452 · Acoustic Schwannoma, Adult Anaplastic Astrocytoma, and more
NCT02175745 · Adult Anaplastic Ependymoma, Adult Anaplastic Oligodendroglioma, and more
NCT00326664 · Childhood Atypical Teratoid/Rhabdoid Tumor, Childhood Central Nervous System Germ Cell Tumor, and more
NCT01462695 · Childhood Cerebellar Anaplastic Astrocytoma, Childhood Cerebral Anaplastic Astrocytoma, and more
Children's Oncology Group
Arcadia, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions